Osivax Appoints Vincent Bille as Chief Manufacturing Officer and Announces Manufacturing Progress fo
Dr. Bille will oversee manufacturing scale-up for broad-spectrum influenza vaccine candidate OVX836 currently in Phase 2 clinical testingCompany achieved accreditation from Belgian authorities for OVX836 batch quality control laboratory in Liège Science ParkLYON, France--(BUSINESS WIRE)--Osivax, a biopharmaceutical...
Source: pharmiweb.com